Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Cash from Financing Activities (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Cash from Financing Activities for 4 consecutive years, with $471000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 74.55% year-over-year to $471000.0; the TTM value through Dec 2025 reached $1.2 million, down 99.4%, while the annual FY2025 figure was $1.2 million, 99.4% down from the prior year.
  • Cash from Financing Activities was $471000.0 for Q4 2025 at Day One Biopharmaceuticals, down from $748000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $200.1 million in Q3 2024, with the low at $48000.0 in Q1 2024.
  • Historically, Cash from Financing Activities has averaged $41.1 million across 4 years, with a median of $1.3 million in 2024.
  • Biggest YoY gain for Cash from Financing Activities was 173895.65% in 2024; the steepest drop was 99.2% in 2024.
  • Over 4 years, Cash from Financing Activities stood at $1.9 million in 2022, then crashed by 68.87% to $597000.0 in 2023, then soared by 210.05% to $1.9 million in 2024, then crashed by 74.55% to $471000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $471000.0 in Q4 2025, $748000.0 in Q2 2025, and $1.9 million in Q4 2024.